Why is Klotho of particular interest for nephrology?
First of all, Klotho is involved in the renal control of calcium, phosphate and vitamin D metabolism. It suppresses phosphate re-absorption in renal proximal tubule, by directly binding to FGF receptors [3] . It regulates Ca 2þ re-absorption in the distal convoluted tubule by stabilizing the TRPV5 Ca 2þ channel in the plasma membrane [4] . It inhibits renal 1-alpha 25 hydroxylase activity and thereby decreases circulating calcitriol levels [5] . It therefore appears to synergize with the renal tubular effects of parathyroid hormone (PTH) on Ca 2þ and phosphate transport, whereas it antagonizes the stimulatory effect of PTH on calcitriol synthesis by the kidney (Figure 1) .
Second, Klotho-deficient mice and fibroblast-growth factor-23 (FGF23)-deficient mice have an identical phenotype including hyperphosphataemia, hypercalcaemia, elevated plasma calcitriol and vascular calcification, in addition to premature ageing [1, 6, 7] . In contrast, over-expression of the Klotho gene extends the lifespan and increases resistance to oxidative stress [8, 9] . These observations were highly suggestive of a close cooperation between Klotho and FGF23 and/or its receptor(s). Others have shown that FGF23 binds to multiple FGF receptors (FGFRs) [10] . Table 1 provides a summary of the presently known role of Klotho in numerous systemic and organ functions and of the biochemical expression of, respectively, its absence and its overfunction in animal models and in man.
Of note, Klotho was the topic of a Translational Nephrology article in a recent issue of NDT, with particular focus on its role in the control of calcium homeostasis [11] .
Regulation of FGF23 signalling by Klotho
The common phenotypes of Klotho and FGF23 overexpression and deletion, respectively, led to the postulate of a common signal transduction pathway. Kurosu et al. [3] showed that Klotho protein directly bound to multiple FGFRs. The Klotho-FGFR complex bound to FGF23 with higher affinity than FGFR or Klotho alone. In addition, Klotho significantly enhanced the ability of FGF23 to induce phosphorylation of FGF receptor substrate and ERK in various types of cells. Very recently, Urakawa et al. [12] made an important further contribution to our understanding of this interaction. They reasoned that the renotropic activity of circulating FGF23 was compatible with the presence of a unique, FGF23-specific receptor in the kidney. In order to prove their hypothesis, they chose different experimental approaches in vitro and in vivo.
Conversion by Klotho of canonical FGF receptor into FGF23-specific receptor
Over-expression of FGF23 in animals and in humans does not reproduce the effects of other FGF molecules, suggesting the existence of a specific FGF receptor (FGFR) for FGF23. Although 22 different FGF molecules have been identified to date, only four genes encode FGFRs with a few additional isoforms by alternative RNA splicing. This suggests that co-receptors could modulate FGFR affinity for the various FGFs. Several lines of evidence support the role of Klotho as one of these co-receptors.
First, Urakawa et al. [12] forced the expression of Klotho respectively in ovary cells and renal cells, which are normally devoid of Klotho. This enabled high affinity binding of FGF23 to the cell surface and made the cells responsive to FGF23 treatment, as demonstrated by the activation of FGF23-dependent postreceptor events, such as the phosphorylation of extracellular signal-regulated kinase (ERK) protein and enhanced mRNA and protein expression of the gene early growth-responsive 1 (Egr-1).
Second, the serum concentration of FGF23 in Klotho-deficient mice was 2000 times higher than in wild-type mice, and they did not respond to pharmacological doses of exogenous FGF23.
Third Figure 2 provides a schematic view of the interaction between FGF23, Klotho and its receptor. From a more general point of view, the discovery of the conversion by Klotho of a non-specific to a specific FGF receptor may apply to other FGF-FGF receptor systems. As pointed out by Urakawa et al. [12] , this form of conversion may represent a new type of receptor modulation and illustrates the potential diversity of biological responses in the presence of similar, and apparently redundant ligand and receptor subtypes.
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